تقرير
أعرض في EDS

Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma.

التفاصيل البيبلوغرافية
العنوان: Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma.
المؤلفون: Williams J; Department of Haematology, Dunedin Hospital, 201 Great King Street, Dunedin 9016, New Zealand., Chiruka S; Department of Haematology, Dunedin Hospital, 201 Great King Street, Dunedin 9016, New Zealand.
المصدر: Case reports in hematology [Case Rep Hematol] 2019 Apr 07; Vol. 2019, pp. 2429098. Date of Electronic Publication: 2019 Apr 07 (Print Publication: 2019).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 101576456 Publication Model: eCollection Cited Medium: Print ISSN: 2090-6560 (Print) Linking ISSN: 20906579 NLM ISO Abbreviation: Case Rep Hematol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Hindawi Pub. Corp.
مستخلص: Mantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin's lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and rituximab-induced acute thrombocytopenia (RIAT) occurring separately, but there are no reports of these occurring in the same patient. Whilst rare, they are important to be aware of as early detection may prevent fatal outcomes.
References: Leukemia. 2001 Jan;15(1):186-7. (PMID: 11243389)
Leuk Lymphoma. 2001 Mar;41(1-2):197-201. (PMID: 11342374)
Clin Lymphoma. 2002 Sep;3(2):117-20. (PMID: 12435285)
Clin Lab Haematol. 2003 Aug;25(4):263-5. (PMID: 12890168)
Am J Hematol. 2004 Apr;75(4):263. (PMID: 15054827)
Am J Hematol. 2005 Jan;78(1):81. (PMID: 15609288)
Am J Emerg Med. 2004 Nov;22(7):629-31. (PMID: 15666284)
Haematologica. 2005 Nov;90 Suppl:ECR23. (PMID: 16266914)
Haematologica. 2006 Aug;91(8 Suppl):ECR36. (PMID: 16923520)
Br J Haematol. 2006 Oct;135(2):273-4. (PMID: 16965386)
Leuk Lymphoma. 2007 Nov;48(11):2239-40. (PMID: 17926181)
Med Oncol. 2009;26(1):45-8. (PMID: 18543133)
Cancer Invest. 2008 Nov;26(9):913-5. (PMID: 19034773)
Am J Hematol. 2009 Apr;84(4):247-50. (PMID: 19260124)
Br J Surg. 2009 Oct;96(10):1114-21. (PMID: 19787754)
Am J Hematol. 2010 Feb;85(2):146. (PMID: 20052746)
Br J Haematol. 2010 Jun;149(6):804. (PMID: 20602622)
Case Rep Med. 2012;2012:351275. (PMID: 22577390)
Leuk Lymphoma. 2013 Dec;54(12):2736-7. (PMID: 23488605)
Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):602-5. (PMID: 23870855)
Intern Med. 2016;55(15):2061-4. (PMID: 27477415)
Rinsho Ketsueki. 2016 Aug;57(8):1018-25. (PMID: 27599418)
BMJ Case Rep. 2017 Feb 8;2017:. (PMID: 28179388)
Intern Med. 2018 Apr 15;57(8):1151-1154. (PMID: 29269668)
Ann Hematol. 1997 Jan;74(1):33-5. (PMID: 9031613)
تواريخ الأحداث: Date Created: 20190516 Latest Revision: 20201001
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC6476069
DOI: 10.1155/2019/2429098
PMID: 31089434
قاعدة البيانات: MEDLINE
الوصف
تدمد:2090-6560
DOI:10.1155/2019/2429098